Szymon Jędrzejczyk

ORCID: 0000-0003-4674-0736
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Cardiac Valve Diseases and Treatments
  • Infective Endocarditis Diagnosis and Management
  • Cardiac Imaging and Diagnostics
  • Aortic Disease and Treatment Approaches
  • Acute Myocardial Infarction Research
  • Ovarian function and disorders
  • Antiplatelet Therapy and Cardiovascular Diseases
  • Cardiac and Coronary Surgery Techniques
  • Venous Thromboembolism Diagnosis and Management
  • Cardiovascular Issues in Pregnancy
  • Efficiency Analysis Using DEA
  • Extracellular vesicles in disease
  • Cardiovascular Function and Risk Factors
  • Health Systems, Economic Evaluations, Quality of Life

Medical University of Warsaw
2019-2024

British Heart Foundation
2022

University of Leeds
2022

Abstract Introduction Transcatheter aortic valve implantation (TAVI) is an established treatment for stenosis (AS) in patients at intermediate and high surgical risk. Circulating extracellular vesicles (EVs) are nanoparticles involved cardiovascular diseases. We aimed to (i) determine the effect of TAVI on plasma concentrations five EV subtypes (ii) evaluate predictive value EVs post-TAVI outcomes. Methods Blood samples were collected 1 day before hospital discharge. Concentrations evaluated...

10.1007/s12265-024-10521-x article EN cc-by Journal of Cardiovascular Translational Research 2024-05-28

Abstract Aims We aimed to investigate the role of aortic valve tissue composition from quantitative cardiac computed tomography angiography (CTA) in patients with severe stenosis (AS) for differentiation disease subtypes and prognostication after transcatheter implantation (TAVI). Methods results Our study included 447 consecutive AS six high-volume centres reporting a prospective nationwide registry TAVI procedures (POL-TAVI), who underwent CTA before TAVI, 224 matched controls normal...

10.1093/ehjci/jeaa304 article EN European Heart Journal - Cardiovascular Imaging 2020-10-23

ENWEndNote BIBJabRef, Mendeley RISPapers, Reference Manager, RefWorks, Zotero AMA Zbroński K, Grodecki Gozdowska R, et al. Use of protamine sulfate during transfemoral transcatheter aortic valve implantation – a preliminary assessment administration rate and impact on complications. Advances in Interventional Cardiology/Postępy w Kardiologii Interwencyjnej. 2020;16(3):306-314. doi:10.5114/aic.2020.99266. APA Zbroński, K., Grodecki, Gozdowska, R., Jędrzejczyk, S., Ostrowska, E., & Wysińska,...

10.5114/aic.2020.99266 article PL cc-by-nc-sa Advances in Interventional Cardiology 2020-01-01

Background: Indications for transcatheter aortic valve implantation (TAVI) have gradually expanded since its introduction. Aims: The aim was to analyze temporal trends in TAVI characteristics based on the experience of a high-volume academic center over period 10 years. Methods: Five hundred and six consecutive (n = 506) patients with 1-year follow-up were divided into early (G1, years 2010–2013, n 130), intermediate (G2, 2014–2016, 164) recent (G3, 2017–2019, 212) groups. Results: Patient’s...

10.33963/kp.a2021.0030 article EN Kardiologia Polska 2021-06-02

KEy wORds aortic stenosis, transcatheter valve implantation, -in -valveAbsTRACT INTROduCTION Transcatheter -valve implantation (ViV -TAVI) has emerged as an alternative to redo surgery in patients with failed surgical bioprosthesis.ObjECTIvEs We evaluated the safety and efficacy of ViV -TAVI Polish after replacement.PATIENTs ANd mEThOds This was a nationwide multicenter registry procedures.Data were collected using online form, clinical follow -up lasted 1 year.REsuLTs From 2008 2020, 130...

10.20452/pamw.16149 article EN Polskie Archiwum Medycyny Wewnętrznej 2021-11-30

Background: Valve-in-valve transcatheter transfemoral mitral valve implantation (ViV-TMVI) is an emerging treatment alternative to reoperation in high-surgical risk patients with failed bioprostheses. Aim: We aimed describe the characteristics of ViV-TMVI and evaluate its 30-day outcomes Polish population. Methods: A nationwide registry was initiated collect data on all bioprosthesis undergoing Poland. This study presents results a clinical echocardiographic follow-up. Results: Overall, 27...

10.33963/kp.a2023.0094 article EN Kardiologia Polska 2023-06-29

AMA Szafarowska M, Rosiński Segiet-Święcicka A, Jędrzejczyk S, Jerzak M. Effect of physiotherapy on infertility treatment in polycystic ovary syndrome patients. Menopause Review/Przegląd Menopauzalny. 2024. doi:10.5114/pm.2024.136439. APA Szafarowska, M., Rosiński, Segiet-Święcicka, A., Jędrzejczyk, S., Jerzak, & (2024). https://doi.org/10.5114/pm.2024.136439 Chicago Monika, Marcin Agnieszka Szymon Michał and Małgorzata Jerzak. "Effect patients". Harvard MLA Monika et al. patients."...

10.5114/pm.2024.136439 article PL cc-by-nc-sa Menopausal Review 2024-01-01

Abstract Background Computed tomography angiography (CTA) performed for procedural planning of transcatheter aortic valve implantation (TAVI) can be used a more complete characterization tissue beyond calcium assessment. Combining quantitative data on both noncalcified and calcified tissues may improve differentiation stenosis (AS) subtypes prognostication post-TAVI. Purpose We sought to noninvasively assess composition with cardiac CTA in patients AS its prognostic vaalue those who...

10.1093/ehjci/ehaa946.0165 article EN European Heart Journal 2020-11-01
Coming Soon ...